Tower Research Capital (TRC)’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,165
| Closed | -$1K | – | 6599 |
|
|
2023
Q1 | $1K | Sell |
7,165
-18,497
| -72% | -$2.58K | ﹤0.01% | 5732 |
|
|
2022
Q4 | $10K | Buy |
25,662
+19,089
| +290% | +$7.44K | ﹤0.01% | 4136 |
|
|
2022
Q3 | $5K | Buy |
6,573
+3,780
| +135% | +$2.88K | ﹤0.01% | 5204 |
|
|
2022
Q2 | $8K | Buy |
2,793
+1,168
| +72% | +$3.35K | ﹤0.01% | 4738 |
|
|
2022
Q1 | $10K | Sell |
1,625
-933
| -36% | -$5.74K | ﹤0.01% | 4401 |
|
|
2021
Q4 | $28K | Buy |
2,558
+1,952
| +322% | +$21.4K | ﹤0.01% | 3324 |
|
|
2021
Q3 | $10K | Sell |
606
-343
| -36% | -$5.66K | ﹤0.01% | 4378 |
|
|
2021
Q2 | $18K | Buy |
949
+77
| +9% | +$1.46K | ﹤0.01% | 4019 |
|
|
2021
Q1 | $13K | Buy |
872
+339
| +64% | +$5.05K | ﹤0.01% | 4232 |
|
|
2020
Q4 | $17K | Buy |
+533
| New | +$17K | ﹤0.01% | 3988 |
|